Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Placebo-controlled Trial of Z-100 Plus Radiation Therapy in Patients With Locally Advanced Cervical Cancer - A Phase III Trial

NCT02247232 is registered in ClinicalTrials.gov with Zeria Pharmaceutical as lead sponsor.

NCT NCT02247232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02247232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Placebo-controlled Trial of Z-100 Plus Radiation Therapy in Patients With Locally Advanced Cervical Cancer - A Phase III Trial
Lead sponsor
Zeria Pharmaceutical
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2014
Completion date
February 25, 2022
Enrollment
793 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer